We, the undersigned organizations, appreciate the opportunity to provide comment on APHIS’ Notice of Intent (NOI) to prepare an environmental impact statement in connection with potential changes to APHIS biotechnology regulations (7 CFR 340). Our member organizations represent a broad cross…
Letters, Testimony & Comments | January 26, 2016 | Food & Farm Innovation, FDA Review, FDA Guidance, FDA Regulations
Food and Drug Administration Docket No. FDA-2015-D-4272; Food Labeling; Voluntary Labeling Indicating Whether Food Has or Has Not Been Derived From Genetically Engineered Atlantic Salmon; Draft Guidance for Industry.
More than 430 organizations representing American innovation in a wide range of industries in all 50 states wrote Senate leaders to express continued concern with S. 1145.
Letters, Testimony & Comments | March 10, 2016 | Biotechnology Innovation Organization (BIO), Intellectual Property, Technology Transfer, International Trade
Innovation And The Global Research Enterprise
WORLD HEALTH ORGANIZATION
GENEVA—NOVEMBER 2007
THEODORE J. ROUMEL
VICE PRESIDENT for RESEARCH, INNOVATION AND COMMERCIALIZATION
UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
Letters, Testimony & Comments | March 10, 2016 | Biotechnology Innovation Organization (BIO), Biotech Basics, Intellectual Property, Technology Transfer